United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $1.24, which may not compare to the analyst estimate ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE